First Horizon Advisors’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $148K | Sell |
276
-10
| -3% | -$4.78K | ﹤0.01% | 604 |
|
|
2025
Q1 | $120K | Sell |
286
-1
| -0.3% | -$434 | ﹤0.01% | 632 |
|
|
2024
Q4 | $119K | Sell |
287
-417
| -59% | -$183K | ﹤0.01% | 646 |
|
|
2024
Q3 | $356K | Buy |
704
+27
| +4% | +$13.1K | 0.01% | 403 |
|
|
2024
Q2 | $330K | Buy |
677
+206
| +44% | +$103K | 0.01% | 411 |
|
|
2024
Q1 | $254K | Buy |
471
+178
| +61% | +$97.3K | 0.01% | 460 |
|
|
2023
Q4 | $163K | Sell |
293
-6
| -2% | -$2.82K | 0.01% | 531 |
|
|
2023
Q3 | $131K | Sell |
299
-2
| -0.7% | -$997 | ﹤0.01% | 561 |
|
|
2023
Q2 | $151K | Sell |
301
-19
| -6% | -$9.11K | 0.01% | 532 |
|
|
2023
Q1 | $160K | Buy |
320
+4
| +1% | +$1.91K | 0.01% | 522 |
|
|
2022
Q4 | $129K | Buy |
316
+9
| +3% | +$3.49K | ﹤0.01% | 551 |
|
|
2022
Q3 | $98K | Sell |
307
-20
| -6% | -$7.35K | ﹤0.01% | 619 |
|
|
2022
Q2 | $114K | Buy |
327
+122
| +60% | +$49.7K | ﹤0.01% | 620 |
|
|
2022
Q1 | $112K | Sell |
205
-245
| -54% | -$129K | 0.01% | 472 |
|
|
2021
Q4 | $296K | Buy |
450
+1
| +0.2% | +$628 | 0.01% | 436 |
|
|
2021
Q3 | $278K | Buy |
449
+133
| +42% | +$89.4K | 0.01% | 445 |
|
|
2021
Q2 | $198K | Sell |
316
-144
| -31% | -$79.5K | 0.01% | 406 |
|
|
2021
Q1 | $223K | Buy |
460
+26
| +6% | +$13K | 0.01% | 364 |
|
|
2020
Q4 | $215K | Sell |
434
-40
| -8% | -$17.9K | 0.01% | 318 |
|
|
2020
Q3 | $186K | Buy |
474
+38
| +9% | +$14K | 0.01% | 314 |
|
|
2020
Q2 | $143K | Buy |
436
+20
| +5% | +$5.79K | 0.01% | 340 |
|
|
2020
Q1 | $100K | Buy |
416
+42
| +11% | +$11K | 0.01% | 366 |
|
|
2019
Q4 | $97K | Hold |
374
| – | – | 0.01% | 435 |
|
|
2019
Q3 | $101K | Sell |
374
-29
| -7% | -$8.07K | 0.01% | 416 |
|
|
2019
Q2 | $110K | Buy |
403
+304
| +307% | +$74.9K | 0.01% | 421 |
|
|
2019
Q1 | $22K | Buy |
+99
| New | +$20.4K | ﹤0.01% | 798 |
|
|
2017
Q2 | – | Sell |
-249
| Closed | -$39K | – | 1431 |
|
|
2017
Q1 | $39K | Buy |
249
+97
| +64% | +$13.4K | ﹤0.01% | 599 |
|
|
2016
Q4 | $16K | Hold |
152
| – | – | ﹤0.01% | 853 |
|
|
2016
Q3 | $16K | Buy |
152
+15
| +11% | +$1.58K | ﹤0.01% | 847 |
|
|
2016
Q2 | $12K | Sell |
137
-8
| -6% | -$687 | ﹤0.01% | 897 |
|
|
2016
Q1 | $12K | Hold |
145
| – | – | ﹤0.01% | 941 |
|
|
2015
Q4 | $10K | Sell |
145
-75
| -34% | -$5.35K | ﹤0.01% | 920 |
|
|
2015
Q3 | $16K | Buy |
+220
| New | +$15.8K | ﹤0.01% | 859 |
|
|
2014
Q1 | – | Sell |
-436
| Closed | -$25K | – | 1427 |
|
|
2013
Q4 | $25K | Buy |
+436
| New | +$22.9K | ﹤0.01% | 665 |
|
Other funds holding IDXX
First Horizon Advisors's IDXX Position: Q2 2025 in Review
First Horizon Advisors reduced its Idexx Laboratories (IDXX) stake by 3.5% in Q2 2025, selling an estimated $4.78K and leaving 276 shares worth $148K. The position accounts for ﹤0.01% of the portfolio, ranked #604.
First Horizon Advisors first reported a position in IDXX in Q4 2013 and has held it in 34 quarters since. The position peaked at $356K in Q3 2024. 1,235 funds tracked by Wall St. Rank hold IDXX as of Q2 2025.
- First Horizon Advisors held 276 shares of Idexx Laboratories worth $148K as of Q2 2025.
- First Horizon Advisors sold 10 Idexx Laboratories shares in Q2 2025, an estimated $4.78K.
- Idexx Laboratories made up ﹤0.01% of First Horizon Advisors's portfolio in Q2 2025, its #604 holding.
- First Horizon Advisors first reported a position in Idexx Laboratories in Q4 2013 and has held it in 34 quarters since.
- First Horizon Advisors's Idexx Laboratories position peaked at $356K in Q3 2024.
- 1,235 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2025.
Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.